Clinical Trial Update: MFOLFOXIRI Plus PD-1 Inhibitor Vs MFOLFOX6 As Neoadjuvant Therapy for Locally Advanced Colon Cancer [Phase 2]

View source ↗

Summary

Phase 2 neoadjuvant trial comparing MFOLFOXIRI plus a PD-1 inhibitor versus MFOLFOX6 for locally advanced colon cancer; not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colon Cancer

Drugs mentioned

• MFOLFOX6
• MFOLFOXIRI
• PD-1 inhibitor

Snippet

Sponsor: Sun Yat-sen University | Conditions: Colon Cancer (stage II & III) | Phase 2 | Status: NOT_YET_RECRUITING